# Study of Tofacitinib in Refractory Dermatomyositis

> **NCT03002649** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 10 (actual)

## Conditions studied

- Dermatomyositis

## Interventions

- **DRUG:** Tofacitinib

## Key facts

- **NCT ID:** NCT03002649
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03002649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03002649, "Study of Tofacitinib in Refractory Dermatomyositis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03002649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*